In clinical studies for the lead indication of multiple sclerosis (MS), Revimmune improves function in most patients and stops progression in over 90 percent of cases refractory to standard therapies.
A new study examined the relationship between physical appearance concerns and psychological distress (depression and anxiety) in patients with RA and lupus.
A new study sheds light on the brain pathways of depression in general and in central nervous system dysfunction in SLE in particular.
Researchers identify the gene control circuitry that enables the body to prevent a wide range of autoimmune diseases.
The Food and Drug Administration (FDA) is alerting health care professionals and patients treated with Rituxan (rituximab) to reports of an emerging risk of a serious side effect in patients receiving or who have used Rituxan.
A comprehensive survey of the serologic proteome in human SLE suggests that severely disrupted chemokine gradients may contribute to the systemic autoimmunity observed.
In a mouse model of systemic lupus erythematosus (SLE), anti-NMDA receptor antibodies have been shown to gain access to the brain during stress, specifically damaging the amygdala (a part of the brain that is involved in emotion) and causing altered emotional responses.
The ebb and flow of such autoimmune diseases as multiple sclerosis, lupus and rheumatoid arthritis has long been a perplexing mystery to scientists. But new findings from the Stanford University School of Medicine bring scientists closer to solving the puzzle, identifying a molecule that appears to play a central role in these relapses.
People with auto-immune conditions like MS, arthritis and lupus can benefit from low impact aerobic exercise — including walking and cycling — that increases in intensity, duration and frequency. A review of studies between 1987 and 2006 shows that 12-week programmes that involved exercising for 30 to 60 minutes, three times a week, yielded the most effective results.
New research at Wake Forest University School of Medicine suggests that certain inhaled asthma medications ? as well as similar chemicals our bodies produce during times of high stress ? may worsen diseases such as asthma, heart failure and lupus that involve inflammation.